Status:
COMPLETED
Evaluation of the Compatibility of Different Eye Lid Retractors to the Direct Selective Laser Trabeculoplasty (DSLT) Procedure
Lead Sponsor:
BelkinVision
Conditions:
OAG - Open-Angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Direct Selective Laser Trabeculoplasty (DSLT) is an emerging therapeutic technology to treat glaucoma. DSLT was previously tested in 2 clinical trials and demonstrated promising safety and efficacy re...
Detailed Description
The DSLT procedure is carried out in the doctor's office while the patient sits in front of the DSLT device (termed the "Eagle" device) for couple of minutes. In this procedure, 120 laser application...
Eligibility Criteria
Inclusion
- Inclusion Criteria.
- Adult volunteers (age ≥18 years old) of both sexes visiting the study eye clinic for any reason.
- Willing and able to participate in the study and to comply with the study procedures.
- Participant capable of giving informed consent.
- Exclusion Criteria:
- Prior incisional ocular surgery or ocular trauma in the tested eye.
- Women who are pregnant.
- Any medical condition that interferes with the subject's ability to sit steady in front of the Eagle device.
- Known allergy to local anaesthesia eye drops.
Exclusion
Key Trial Info
Start Date :
June 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05271734
Start Date
June 6 2021
End Date
August 15 2022
Last Update
January 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akhali Mzera Eye Clinic
Tbilisi, Georgia